# Allogene Therapeutics (ALLO): value investors who own it

1 value investor held Allogene Therapeutics in their Q3 2026 13F, led by Horizon Kinetics. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Horizon Kinetics | 0.0% | $35k | Trimmed -4.6% | 14 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/allo). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.